We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+29.19%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$15.1M
AUM Growth
-$5.08M
Cap. Flow
-$6.77M
Cap. Flow %
-44.72%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
+$6.77M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.58B
$15M 99.32%
3,804,788
– –
CORV
2
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$103K 0.68%
250,000
-4,075,000
-94% -$6.77M

Similar funds

SFCM
Savoir Faire Capital Management Norwalk, Connecticut $161M AUM 3.8% 1-Year Est. Return
LWM
Lighthouse Wealth Management Ashland, Ohio $161M AUM 19.46% 1-Year Est. Return
MWM
Mascagni Wealth Management Clinton, Mississippi $161M AUM 26.58% 1-Year Est. Return
MCM
MidAtlantic Capital Management Richmond, Virginia $161M AUM 18.73% 1-Year Est. Return
BFS
Burr Financial Services Pleasant Hill, California $161M AUM 80.86% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $161M AUM 39.43% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $161M AUM 19.9% 1-Year Est. Return
BWM
Bosman Wealth Management Redlands, California $161M AUM 115.22% 1-Year Est. Return

Summer Road's Q4 2019 Portfolio in Review

As of Q4 2019, Summer Road held 2 positions worth $15.1M, down 25% from $20.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summer Road withdrew a net $6.77M in Q4 2019, reducing 1 holding. Its largest reduction was Correvio Pharma Corp. Ordinary Shares (Canada), cutting an estimated $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Summer Road's biggest Q4 2019 reduction was Correvio Pharma Corp. Ordinary Shares (Canada), cutting an estimated $6.77M.
  • Summer Road's ten largest holdings make up 100% of its $15.1M portfolio in Q4 2019.
  • Summer Road opened 0 new positions and closed 0 in Q4 2019.
  • Summer Road's portfolio value fell 25% quarter-over-quarter to $15.1M.

Based on Summer Road's 13F filing for Q4 2019, filed 14 Feb 2020.